Company / Net Income
Nuvation Bio Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$204.6M
FY2025
5-year range
-$567.9M / -$75.8M
FY2021-FY2025
Trend
+64.0%
vs FY2024
Sector context
#159 of 216
Health Care
What the data says
At -$205M, Nuvation Bio Inc.'s net income ranks #159 of 216 in the Health Care sector. Net Income has fluctuated over the past 6 years, ranging from -$568M in FY2024 to -$42M in FY2020.
Based on SEC 10-K filings.
-$205M in FY2025.
Declined from -$76M to -$205M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#159 of 216 in Health CareTop 74% of 216This company -$204.6M Sector average $454.3M
▼
-145.0% below sector average
Key checks
Key Insights
- In FY2025, net income increased 64.0% year-over-year.
- Ranks #159 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$204.6M | +64.0% |
| FY2024 | -$567.9M | -649.2% |
| FY2023 | -$75.8M | +27.3% |
| FY2022 | -$104.2M | -20.0% |
| FY2021 | -$86.8M | -108.5% |
| FY2020 | -$41.7M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026